Werner Robert F. reported grant involving 3,641 shares of Twist Bioscience Corp at $0.00 for $0 on Nov 16, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Accounting Officer
Chief Accounting Officer
Filed Nov 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
3,641Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
53,212Direct
Trade date
Nov 16, 2026Grant
Filed
Nov 18, 2026, 4:05 PM ET2-day reporting delay
Accession
0001214659-26-014544Code A · Transaction 405635
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 16, 2026Sell1,637$103.69−$169,737.26Trade 405634
2 transaction rows in this filing. Joint filers share the same rows.

TWST price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TWST · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +19%1w ago +21%1d ago −0.4%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (""PSUs""). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a ""sell to cover"" transaction and do not represent discretionary trades by the Reporting Person. F2: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 16, 2026 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.